Biotech: Time For A Pause To Start 2026
Source: SeekingAlpha
2026-01-02 06:52:42 ET
The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the administration in April. This ETF is up around 20% from my last article on it early in October, when I was still bullish on the sector....
Read the full article on Seeking Alpha
For further details see:
Biotech: Time For A Pause To Start 2026
Novartis AG
NASDAQ: NVS
NVS Trading
-1.18% G/L:
$143.635 Last:
830,683 Volume:
$144.01 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
